Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate
about
A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study.Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors.Is there something other than imatinib mesilate in therapeutic options for GIST?The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors.Antiangiogenic effects of topically administered multiple kinase inhibitor, motesanib (AMG 706), on experimental choroidal neovascularization in mice.Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors.Motesanib and advanced NSCLC: experiences and expectations.Receptor tyrosine kinase inhibitors: Are they real tumor killers?
P2860
Q30414010-C92C501E-40FB-4751-B15F-B55D1282EFB6Q34031293-6761C07D-168B-44B1-853F-8FCE90B3F9F2Q34207379-754F9B5E-A984-4273-99AC-CD3069CC66B0Q34725749-2E930B7F-DE31-4402-B3EB-508E27F4525DQ34862792-C9B3DD61-2E3D-4726-940B-7654AA43AE36Q36180074-6E756F1B-6045-4146-821D-014E5E8AC97EQ37870920-0538C0D2-62E6-4DBF-90BA-BE4D1810F6BCQ38365290-E85636E3-CC76-46A3-BD72-0CBDAFC5BCDB
P2860
Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phase II study of motesanib in ...... exposure to imatinib mesylate
@ast
Phase II study of motesanib in ...... exposure to imatinib mesylate
@en
type
label
Phase II study of motesanib in ...... exposure to imatinib mesylate
@ast
Phase II study of motesanib in ...... exposure to imatinib mesylate
@en
prefLabel
Phase II study of motesanib in ...... exposure to imatinib mesylate
@ast
Phase II study of motesanib in ...... exposure to imatinib mesylate
@en
P2093
P2860
P1476
Phase II study of motesanib in ...... exposure to imatinib mesylate
@en
P2093
Akira Sawaki
Hideo Baba
Koji Murakami
Masato Koseki
Tatsuo Kanda
Toshirou Nishida
Yasuhide Yamada
Yoshito Komatsu
Yu-Nien Sun
P2860
P2888
P304
P356
10.1007/S00280-009-1103-9
P577
2009-08-19T00:00:00Z
P5875
P6179
1040100039